Johnson & Johnson Q2 Earnings Outlook
On Tuesday, July 16, Johnson & Johnson (NYSE: JNJ) will release its latest earnings report. Here is Benzinga's outlook for the company.
Earnings and Revenue
Johnson & Johnson EPS is expected to be around $2.43, according to sell-side analysts. Sales will likely be near $20.29 billion.
Johnson & Johnson earnings in the same period a year ago was $2.10. Quarterly sales came in at $20.83 billion. If the company were to match the consensus estimate when it reports Tuesday, earnings would be up 15.71%. Sales would have fallen 2.59% from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:
Quarter | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 |
EPS Estimate | 2.08 | 1.95 | 2.03 | 2.06 |
EPS Actual | 2.100 | 1.97 | 2.05 | 2.1 |
Stock Performance
Shares of Johnson & Johnson were trading at $134.30 as of July 15. Over the last 52-week period, shares are up 5.12%. Given that these returns are generally positive, long-term shareholders are probably satisfied going into this earnings release.
Analyst estimates are adjusted higher for EPS and revenues over the past 90 days. The most common rating by analysts on Johnson & Johnson stock is a Neutral. The strength of this rating has maintained conviction over the past three months.
Conference Call
Johnson & Johnson is scheduled to hold a conference call at 8:30 a.m. ET and it can be accessed here: https://johnsonandjohnson.gcs-web.com/events-and-presentations
See more from Benzinga
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
